SARCULATOR vs ASCO Guidelines Kullanım & İstatistikleri

This app is meant to be used only by physicians and it is not meant to make clinical decisions (the clinical usefulness of the two models has not been tested) but to be used as an informative tool to improve the predictive capability of a physician. Two kinds of predictions are possible: - RPS: 5-year overall survival (OS) and 5-year disease-free survival (DFS) in primary resected retroperitoneal sarcoma (RPS) patients. . - STS: 5- and 10-year overall survival (OS) and cumulative incidence of distant metastasis (CCI of DM) in primary resected extremity STS patients.
  • Apple App Store
  • BOŞTA
  • Medikal

Mağaza Sıralaması

- -

The ASCO Guidelines app is your go-to tool for implementing guideline recommendations into practice. This user-friendly app provides health care providers, patients, and caregivers with the recommended cancer care options for a variety of cancer types. It also includes interactive tools to inform treatment decisions at the point of care, thus increasing the quality of care provided to patients. The ASCO app is free to members and nonmembers, kept up to date, and will continue to grow as more guidelines and tools are added.
  • Apple App Store
  • BOŞTA
  • Medikal

Mağaza Sıralaması

- -

SARCULATOR ile ASCO Guidelines için sıralama karşılaştırması

Son 28 gündeki SARCULATOR sıralama trendini ASCO Guidelinesile karşılaştırın

Rank

Mevcut veri yok

SARCULATOR vs. ASCO Guidelines ülke karşılaştırmasına göre sıralama

Son 28 gündeki SARCULATOR sıralama trendini ASCO Guidelinesile karşılaştırın

Tüm kategoriler

Mevcut veri yok

Medikal

Uygulama
En İyi Ülke
Sıralama
- -
- -
#174

Ücretsiz deneme sürümümüzü kullanarak istediğiniz siteyle karşılaştırın

Başlayın
SARCULATOR VS.
ASCO Guidelines

Ocak 8, 2025